You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCRT

Showing 1 - 25 of 280
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
  • Singapore, Singapore
  • +1 more
Oct 16, 2023

Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

Not yet recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 23, 2023

Using Microbiome to Predict Durvalumab Toxicity in Post-

Recruiting
  • NSCLC, Stage III
  • Locally Advanced Lung Carcinoma
    • Kansas City, Kansas
    • +1 more
    May 17, 2022

    Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Split-course hypo-CCRT
    • +2 more
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer Center
    Aug 26, 2023

    Cervical Cancer Trial (CCRT, Surgical debulking of bulky or multiple lymph nodes)

    Not yet recruiting
    • Cervical Cancer
    • CCRT
    • Surgical debulking of bulky or multiple lymph nodes
    • (no location specified)
    Jul 19, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (gemcitabine and cisplatin,

    Recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • gemcitabine and cisplatin
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 4, 2022

    Rectal Cancer Trial in Kaohsiung (for excise, nutrition consultant, nutrition supplement and psychologic intervention.)

    Not yet recruiting
    • Rectal Cancer
    • for excise, nutrition consultant, nutrition supplement and psychologic intervention.
    • Kaohsiung, Taiwan
      Chang Gung Memorial Hospital
    Dec 27, 2022

    Cervical Carcinoma Trial in Guangzhou (CCRT+TIL)

    Active, not recruiting
    • Cervical Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Nov 13, 2021

    Nasopharyngeal Carcinoma Trial in Guangzhou (CCRT+Nimotuzumab, CCRT alone)

    Active, not recruiting
    • Nasopharyngeal Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen Universitty Cancer Center
    Nov 22, 2021

    Non Small Cell Lung Cancer Trial in Australia, United States (Tislelizumab, Durvalumab, Chemotherapy)

    Recruiting
    • Non Small Cell Lung Cancer
    • Bolivar, Missouri
    • +7 more
    Oct 21, 2021

    Early-onset Schizophrenia, Psychotic Disorders, Cognitive Remediation Therapy Trial in Barcelona (Computerized Cognitive

    Recruiting
    • Early-onset Schizophrenia
    • +3 more
    • Computerized Cognitive Remediation Therapy
    • Treatment as Usual
    • Barcelona, Spain
      Hospital Sant Joan de Deu
    Jun 20, 2022

    Esophageal Cancer Trial in Taoyuan City (Add-on Brachytherapy, "BRAXX" Esophageal Brachytherapy Applicator)

    Recruiting
    • Esophageal Cancer
    • Add-on Brachytherapy
    • "BRAXX" Esophageal Brachytherapy Applicator
    • Taoyuan City, Taiwan
      Linkou Chang Gung Memorial Hospital
    Nov 22, 2021

    Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
    • RP3
    • +3 more
    • (no location specified)
    Feb 21, 2023

    Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)

    Not yet recruiting
    • Limited Stage Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 12, 2022

    Newly Diagnosed Glioblastoma Trial in China, Hong Kong (TJ107, TJ107 )

    Recruiting
    • Newly Diagnosed Glioblastoma
    • Shenzhen, Guangdong, China
    • +15 more
    Jul 6, 2022

    Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Mar 6, 2023

    Schizophrenia Trial in Shanghai (Cognitive Remediation Therapy, Clozapine)

    Completed
    • Schizophrenia
    • Shanghai, Shanghai, China
      Huangpu District Mental Health Center
    Dec 19, 2021

    Head and Neck Squamous Cell Carcinoma, Oral Mucositis Trial in Korea, Republic of, United States (MIT-001 plus CCRT)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Oral Mucositis
    • MIT-001 plus CCRT
    • Gilbert, Arizona
    • +14 more
    Jan 27, 2022

    Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1

    Recruiting
    • Nasopharyngeal Carcinoma
    • De-escalation Therapy
    • Cisplatin-based induction chemotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 16, 2023

    Nasopharyngeal Carcinoma Trial in Hangzhou, (Anlotinib HCl, induction chemo, concurrent chemoradiation)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Anlotinib hydrochloride
    • +2 more
    • Hangzhou,, Zhejiang, China
      Zhejiang Cancer Hospital
    Jan 30, 2022

    Glioblastoma Trial in Taipei City (CCRT, Temozolomide, Siroquine)

    Recruiting
    • Glioblastoma
    • CCRT
    • +2 more
    • Taipei City, Taiwan
    • +1 more
    May 10, 2021

    Cervical Cancer Trial in Chengdu (NACT, CCRT, Brachytherapy)

    Not yet recruiting
    • Cervical Cancer
    • Chengdu, Sichuan, China
      Sicchuan cancer hospital
    Dec 28, 2021

    Esophageal Cancer Trial in Daegu (chemoradiotherapy)

    Recruiting
    • Esophageal Cancer
    • chemoradiotherapy
    • Daegu, Korea, Republic of
      Kyungpook National University Medical Canter
    Aug 8, 2021

    Pancreatic Cancer Trial in Seoul (Gemcitabine, Durvalumab)

    Recruiting
    • Pancreatic Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Mar 15, 2021

    Head Neck Cancer Trial in Seoul (CCRT with weekly docetaxel & cisplatin)

    Completed
    • Head and Neck Cancer
    • CCRT with weekly docetaxel & cisplatin
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Mar 18, 2021